Shanghai Shyndec Pharmaceutical Co., Ltd. — Investor Relations & Filings

Shanghai Shyndec Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and distribution of chemical active pharmaceutical ingredients (APIs) and finished dosage forms. As a key industrial entity within the Sinopharm group, the company focuses on therapeutic areas such as anti-infectives, cardiovascular diseases, endocrine disorders, and oncology. Its extensive product portfolio includes various formulations, including solid orals and injectables. Shyndec operates multiple manufacturing facilities compliant with international Good Manufacturing Practice (GMP) standards, integrating a comprehensive supply chain from raw material synthesis to final drug preparation. The organization prioritizes technological advancement and quality control to provide pharmaceutical solutions for diverse clinical needs across global markets.